Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Benlysta
Pharma
Sandoz, Henlius agree to $322M deal for 3 biosimilars
Sandoz has collaborated with Henlius to gain commercialization rights to three biosimilars for $100.5M up front and $322M if milestones are reached.
Kevin Dunleavy
Aug 17, 2026 10:46am
FDA rejects AZ's subcutaneous version of lupus drug Saphnelo
Feb 3, 2026 9:55am
AZ touts phase 3 lupus win for subcutaneous Saphnelo
Jan 6, 2026 11:44am
Samsung Bio shells out $280M to secure first US production site
Dec 22, 2025 9:14am
Roche's cancer med Gazyva scores FDA nod in lupus nephritis
Oct 20, 2025 10:15am
Lupus landscape 'poised for evolution'
Sep 17, 2024 9:55am
